Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest ArticlesMet receptor tyrosine kinase transactivation is involved in proteinase-activated receptor-2-mediated hepatocellular carcinoma cell invasion
Carcinogenesis, 09/03/09
Kaufmann R et al. – The expression of proteinase–activated receptor (PAR)2 in human hepatocellular carcinoma (HCC) was established by reverse transcription–polymerase chain reaction, confocal immunofluorescence and electron microscopy in permanent cell lines, primary HCC cell cultures and HCC tumor tissue. The study establishes an important link between the PAR2 and Met receptor tyrosine kinase signaling in promoting HCC cell invasion.
Related Articles
The Role of MET Activation in Determining the Sensitivity to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors
Molecular Cancer Research, 10/09/09
Relevance Score: 67%
Effects of Src inhibitors on cell growth and epidermal growth factor receptor and MET signaling in gefitinib-resistant non-small cell lung cancer cells with acquired MET amplification
Cancer Science, 10/08/09
Relevance Score: 66%
Evolution, body composition, insulin receptor competition, and insulin resistance
Preventive Medicine, 11/02/09
Relevance Score: 47%
Targeting the NMDA Receptor Subunit NR2B for the Treatment of Neuropathic Pain
Neurotherapeutics, 10/05/09
Relevance Score: 47%
Cardiovascular disease-related genes and regulation by diet
Current Atherosclerosis Reports, 11/17/09
Relevance Score: 46%
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Evidence for distinct alterations in the FGF axis in prostate cancer progression to an aggressive clinical phenotype
The Journal of Pathology, 12/11/09
Oncogenic NRF2 mutations in squamous cell carcinomas of oesophagus and skin
The Journal of Pathology, 12/11/09
Characterization of the molecular differences between ovarian endometrioid carcinoma and ovarian serous carcinoma
The Journal of Pathology, 12/11/09
Today in Hepatobiliary/Pancreas...keeping you current
Receive free subspecialty "5-minute updates" via email
Depth of invasion determines the postresectional prognosis for patients with T1 extrahepatic cholangiocarcinoma
Cancer, 12/11/09
Folate intake, post–folic acid grain fortification, and pancreatic cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
American Journal of Clinical Nutrition, 12/11/09
Erlotinib 150 mg daily plus chemotherapy in advanced pancreatic cancer: an interim safety analysis of a multicenter, randomized, cross-over phase III trial of the Arbeitsgemeinschaft Internistische Onkologie
Anti-Cancer Drugs, 12/10/09
Sponsor
Article Search
Sponsor
Sponsor